[Antilipemics: results of large studies]

Related Experiment Video

Updated: Sep 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Gérald Luc1

  • 1Département d'Athérosclérose, Inserm UR545, Institut Pasteur de Lille, Service de Médecine Interne A, CHU de Lille, Hôpital Huriez, Lille, France. gerald.luc@pasteur-lille.fr

Therapie
|June 26, 2003
PubMed

Insights

Hypolipidaemic drugs effectively prevent cardiovascular diseases by reducing heart attacks and coronary deaths. Their use is recommended for individuals with high atherosclerotic risk, including those with existing heart disease or diabetes.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Context:

  • Cardiovascular diseases (CVDs) represent a significant public health concern.
  • Hyperlipidaemia is a primary risk factor contributing to CVD development.
  • Clinical trials have evaluated various hypolipidaemic drugs for efficacy.

Purpose:

  • To assess the effectiveness of hypolipidaemic drugs in preventing cardiovascular events.
  • To determine the impact of these drugs on mortality rates.
  • To establish recommendations for drug use in high-risk populations.

Summary:

  • Hypolipidaemic drugs, including statins, colestyramine, and gemfibrozil, have demonstrated efficacy in reducing nonfatal myocardial infarction and coronary death.
  • Statins, in particular, have been shown to decrease both coronary and overall mortality.
  • The effectiveness of these drugs is consistent across different baseline LDL-cholesterol levels, atherosclerotic risk profiles, ages, and genders.

Impact:

  • The proven efficacy supports the recommendation of hypolipidaemic drug therapy for individuals at high risk of atherosclerosis.
  • Particular emphasis is placed on patients with a history of coronary heart disease or diabetes mellitus.
  • These findings contribute to evidence-based strategies for cardiovascular disease prevention and management.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...